-
Black-Box Warning About Anaphylaxis Being Put On Asthma Drug Xolair
Potentially Deadly Allergic Reaction Occurs Twice As Often As Previously Stated On Medication's Prior Label (Posted by Tom Lamb at DrugInjuryWatch.com) The FDA announced on July 2, 2007 that the package insert, or label,…
-
FDA Letter Concerning Sybmyax May Result In More Zyprexa Lawsuits For Lilly
According To Bloomberg Report, FDA Wants Information About Weight Gain And High Levels Of Blood Sugar Added To Zyprexa Label (Posted by Tom Lamb at DrugInjuryWatch.com) On June 29, 2007 Bloomberg published an article…
-
Safety Of Avandia Discussed At Diabetes Meeting By Doctors Nissen, Buse, And Home
Issues Include Publishing Of May 2007 NEJM Article And Whether To Keep Diabetic Patients On Avandia (Posted by Tom Lamb at DrugInjuryWatch.com) A lively discussion during a session about Avandia was the highlight of…
-
June 2007 FDA “Patient Safety News” Videos For Doctors Online
Covers Zelnorm, Permax, And Zyvox As Well As Drug Mix-Ups And Hazards of Buying Prescription Drugs Online (Posted by Tom Lamb at DrugInjuryWatch.com) The FDA’s Patient Safety News (PSN) is a series of monthly…
-
FDA Explains How It Is Trying To Manage Drug Safety Issues
FDA’s Paul Seligman Answers Some Questions About The Agency’s Drug Oversight Performance (Posted by Tom Lamb at DrugInjuryWatch.com) Paul Seligman, M.D., M.P.H., is Associate Director of Safety Policy and Communication in FDA’s Center for…
-
Long-Awaited Natrecor Trial Starts To Enroll Patients In June 2007
Scios Inc. Finally Going To Assess Benefit / Risk Profile Of Natrecor In Large Trial Of Patients With Acutely Decompensated Heart Failure On June 8, 2007 Scios, Inc. let the public know that it…
